Back to top
Jin Medical International Ltd. (ZJYL)
(Delayed Data from NSDQ)
$3.01 USD
3.01
172,882
+0.28 (10.26%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $2.96 -0.05 (-1.66%) 7:58 PM ET
NA Value NA Growth NA Momentum NA VGM
View All Zacks #1 Ranked Stocks
Balance Sheet
Fiscal Year End for Jin Medical International Ltd falls in the month of December.
All items in Millions except Per Share data.
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | -99,999 | 17 | -99,999 | -99,999 | -99,999 |
| Receivables | NA | 8 | NA | NA | NA |
| Notes Receivable | NA | NA | NA | NA | NA |
| Inventories | NA | 5 | NA | NA | NA |
| Other Current Assets | NA | 1 | NA | NA | NA |
| Total Current Assets | NA | 31 | NA | NA | NA |
| Net Property & Equipment | NA | 1 | NA | NA | NA |
| Investments & Advances | NA | NA | NA | NA | NA |
| Other Non-Current Assets | NA | NA | NA | NA | NA |
| Deferred Charges | NA | 0 | NA | NA | NA |
| Intangibles | NA | 0 | NA | NA | NA |
| Deposits & Other Assets | NA | NA | NA | NA | NA |
| Total Assets | NA | 33 | NA | NA | NA |
| Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|---|---|
| Notes Payable | NA | 4 | NA | NA | NA |
| Accounts Payable | NA | 3 | NA | NA | NA |
| Current Portion Long-Term Debt | NA | NA | NA | NA | NA |
| Current Portion Capital Leases | NA | NA | NA | NA | NA |
| Accrued Expenses | NA | 0 | NA | NA | NA |
| Income Taxes Payable | NA | 0 | NA | NA | NA |
| Other Current Liabilities | NA | 1 | NA | NA | NA |
| Total Current Liabilities | NA | 9 | NA | NA | NA |
| Mortgages | NA | NA | NA | NA | NA |
| Deferred Taxes/Income | NA | NA | NA | NA | NA |
| Convertible Debt | NA | NA | NA | NA | NA |
| Long-Term Debt | NA | NA | NA | NA | NA |
| Non-Current Capital Leases | NA | NA | NA | NA | NA |
| Other Non-Current Liabilities | NA | NA | NA | NA | NA |
| Minority Interest (Liabilities) | NA | NA | NA | NA | NA |
| Total Liabilities | NA | 9 | NA | NA | NA |
| Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|---|---|
| Preferred Stock | NA | NA | NA | NA | NA |
| Common Stock (Par) | NA | 0 | NA | NA | NA |
| Capital Surplus | NA | 6 | NA | NA | NA |
| Retained Earnings | NA | 17 | NA | NA | NA |
| Other Equity | NA | 1 | NA | NA | NA |
| Treasury Stock | NA | NA | NA | NA | NA |
| Total Shareholder's Equity | NA | 24 | NA | NA | NA |
| Total Liabilities & Shareholder's Equity | NA | 33 | NA | NA | NA |
| Total Common Equity | 0 | 100,023 | 0 | 0 | 0 |
| Shares Outstanding | 155.00 | NA | NA | NA | NA |
| Book Value Per Share | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for Jin Medical International Ltd falls in the month of December.
All items in Millions except Per Share data.
| 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | -99,999 | 26 | -99,999 | 17 | -99,999 |
| Receivables | NA | 5 | NA | 8 | NA |
| Notes Receivable | NA | NA | NA | 0 | NA |
| Inventories | NA | 5 | NA | 5 | NA |
| Other Current Assets | NA | 2 | NA | 1 | NA |
| Total Current Assets | NA | 38 | NA | 31 | NA |
| Net Property & Equipment | NA | 1 | NA | 1 | NA |
| Investments & Advances | NA | NA | NA | 0 | NA |
| Other Non-Current Assets | NA | NA | NA | 0 | NA |
| Deferred Charges | NA | 0 | NA | 0 | NA |
| Intangibles | NA | 1 | NA | 0 | NA |
| Deposits & Other Assets | NA | NA | NA | 0 | NA |
| Total Assets | NA | 41 | NA | 33 | NA |
| Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
|---|---|---|---|---|---|
| Notes Payable | NA | 10 | NA | 4 | NA |
| Accounts Payable | NA | 3 | NA | 3 | NA |
| Current Portion Long-Term Debt | NA | NA | NA | 0 | NA |
| Current Portion Capital Leases | NA | NA | NA | 0 | NA |
| Accrued Expenses | NA | 1 | NA | 0 | NA |
| Income Taxes Payable | NA | 1 | NA | 0 | NA |
| Other Current Liabilities | NA | 1 | NA | 1 | NA |
| Total Current Liabilities | NA | 15 | NA | 9 | NA |
| Mortgages | NA | NA | NA | 0 | NA |
| Deferred Taxes/Income | NA | NA | NA | 0 | NA |
| Convertible Debt | NA | NA | NA | 0 | NA |
| Long-Term Debt | NA | NA | NA | 0 | NA |
| Non-Current Capital Leases | NA | NA | NA | 0 | NA |
| Other Non-Current Liabilities | NA | NA | 0 | NA | |
| Minority Interest (Liabilities) | NA | NA | NA | 0 | NA |
| Total Liabilities | NA | 15 | NA | 9 | NA |
| Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
|---|---|---|---|---|---|
| Preferred Stock | NA | NA | NA | 0 | NA |
| Common Stock (Par) | NA | 0 | NA | 0 | NA |
| Capital Surplus | NA | 7 | NA | 6 | NA |
| Retained Earnings | NA | 18 | NA | 17 | NA |
| Other Equity | NA | 1 | NA | 1 | NA |
| Treasury Stock | NA | NA | NA | 0 | NA |
| Total Shareholder's Equity | NA | 26 | NA | 24 | NA |
| Total Liabilities & Shareholder's Equity | NA | 41 | NA | 33 | NA |
| Total Common Equity | 0 | 100,025 | 0 | 24 | 0 |
| Shares Outstanding | 155.00 | 155.00 | 155.00 | 155.00 | 155.00 |
| Book Value Per Share | 0.00 | 645.32 | 0.00 | 0.15 | 0.00 |